Table 3.
Study | N | Age of hypertension onset (exposure) | Outcome | Odds ratio (95% CI) | p-value |
---|---|---|---|---|---|
Buck et al. [27] | 10,313 | 40–49 years | CVD eventa | 5.2 (n/a) | n/a |
50–59 years | 1.8 (n/a) | n/a | |||
60–65 years | 1.2 (n/a) | n/a | |||
No hypertension | Ref. | ||||
Niiranen et al. [53] | 3,614 | <45 years | CVD death | 2.19 (1.77–2.70) | p < .001 |
45–54 years | 2.10 (1.67–2.63) | n/a | |||
55–64 years | 1.86 (1.48–2.34) | n/a | |||
≥65 years | 1.47 (1.16–1.87) | p = .001 | |||
No hypertension | Ref. | ||||
Niiranen et al. [53] | 3,614 | <45 years | CHD death | 2.26 (1.75–2.93) | p < .001 |
45–54 years | 2.18 (1.64–2.90) | n/a | |||
55–64 years | 1.71 (1.26–2.32) | n/a | |||
≥65 years | 1.36 (0.98–1.87) | p = .07 | |||
No hypertension | Ref. |
Abbreviations: CVD: cardiovascular disease; CHD: coronary heart disease; n/a: not applicable.
aMyocardial infarction, stroke, congestive heart failure, or renal failure.